🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jennifer Peterson

Jacksonville College

ORCID: 0000-0001-7458-1504

Also affiliated with WinnMed, Massachusetts General Hospital, Global Cancer Institute, Mayo Clinic in Florida, Center for Cancer Research

MedicinePhysics and Astronomy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile
0.217Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Empowering the biomedical research community: Innovative SAS deployment on the All of Us Researcher Workbench

Journal of the American Medical Informatics Association(2024)10.1093/jamia/ocae216
Top 63%
0.217DataRank
Top 63%2 citations

Cathy Shyr, Moira Rose Dillon, Zhongjie Liu, Jennifer Peterson, Chris St Jeor +24 more

Papers

Driven by 7 papers — median percentile 37. Top paper: “Integrated Radiology, Pathology, and Pharmacy Program to Accelerate Access to Osimertinib”.

Integrated Radiology, Pathology, and Pharmacy Program to Accelerate Access to Osimertinib

JCO Oncology Practice(2023)10.1200/op.23.00031
N/A
0.330DataRank · unranked
8 citations

Amanda Manoogian, Nicholas A. Jessop, N. Zeke Georgantas, Florian J. Fintelmann, Alexander Farahani +17 more

Empowering the biomedical research community: Innovative SAS deployment on the All of Us Researcher Workbench

Journal of the American Medical Informatics Association(2024)10.1093/jamia/ocae216
Top 63%
0.217DataRank
Top 63%2 citations

Cathy Shyr, Moira Rose Dillon, Zhongjie Liu, Jennifer Peterson, Chris St Jeor +24 more

Real World Long-term Follow-up Experience with Yttrium-90 ibritumomab tiuxetan in Previously Untreated Patients with Low-Grade Follicular Lymphoma and Marginal Zone Lymphoma

Clinical Lymphoma Myeloma & Leukemia(2022)10.1016/j.clml.2022.03.004
N/A
0DataRank · unranked
8 citations

Jennifer Peterson, Bradford S. Hoppe, Jennifer Jiang, Gregory A. Wiseman, Thomas E. Witzig +2 more

Efficacy and Tolerability of ALK/MET Combinations in Patients With ALK-Rearranged Lung Cancer With Acquired MET Amplification: A Retrospective Analysis

JTO Clinical and Research Reports(2023)10.1016/j.jtocrr.2023.100534
N/A
0DataRank · unranked
13 citations

Lesli A. Kiedrowski, Rebecca S. Heist, W. Marston Linehan, Catherine B. Meador, Elizabeth Krueger +7 more

Structural and functional analysis of lorlatinib analogs reveals roadmap for targeting diverse compound resistance mutations in ALK-positive lung cancer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.07.16.452681
N/A
0DataRank · unranked
2 citations

Ted W. Johnson, Ibiayi Dagogo‐Jack, Mari Mino–Kenudson, Theodore R. Johnson, Ping Wei +16 more

Yttrium-90 Ibritumomab Tiuxetan is Cost-Effective Compared to Bendamustine + Rituximab in Low-grade Lymphomas

Clinical Lymphoma Myeloma & Leukemia(2023)10.1016/j.clml.2023.01.010
N/A
0DataRank · unranked
2 citations

Bijan J. Borah, James P. Moriarty, Ruchita Dholakia, Liuyan Jiang, Ke Li +6 more

Efficacy and Safety of Dose-Escalated Alectinib in Patients With Metastatic ALK-Positive NSCLC and Central Nervous System Relapse on Standard-Dose Alectinib

JTO Clinical and Research Reports(2024)10.1016/j.jtocrr.2024.100645
N/A
0DataRank · unranked
4 citations

Jiyoon Kang, Beow Y. Yeap, Jennifer Peterson, Andrew Do, Justin F. Gainor +3 more